DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
de Bono JS, Oudard S, Ozguroglu M. et al
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Lancet (London, England) 2010;
376: 1147-1154 . doi:10.1016/s0140-6736(10)61389-x
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.